Steward Partners Investment Advisory LLC Has $146,000 Stock Holdings in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Steward Partners Investment Advisory LLC lessened its position in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBEGet Rating) by 83.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,354 shares of the company’s stock after selling 11,931 shares during the quarter. Steward Partners Investment Advisory LLC owned about 0.06% of Invesco Dynamic Biotechnology & Genome ETF worth $146,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Artemis Wealth Advisors LLC acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF during the first quarter valued at $4,144,000. Bank of America Corp DE lifted its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 8.4% during the fourth quarter. Bank of America Corp DE now owns 46,255 shares of the company’s stock valued at $3,294,000 after acquiring an additional 3,588 shares during the period. Anfield Capital Management LLC lifted its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 1.2% during the fourth quarter. Anfield Capital Management LLC now owns 26,795 shares of the company’s stock valued at $1,908,000 after acquiring an additional 315 shares during the period. YHB Investment Advisors Inc. lifted its stake in Invesco Dynamic Biotechnology & Genome ETF by 8.3% in the first quarter. YHB Investment Advisors Inc. now owns 23,309 shares of the company’s stock valued at $1,446,000 after buying an additional 1,784 shares during the period. Finally, Kestra Advisory Services LLC acquired a new position in Invesco Dynamic Biotechnology & Genome ETF in the first quarter valued at about $336,000.

Invesco Dynamic Biotechnology & Genome ETF Price Performance

NYSEARCA:PBE opened at $60.40 on Tuesday. Invesco Dynamic Biotechnology & Genome ETF has a 1-year low of $51.39 and a 1-year high of $79.92. The business’s 50-day moving average price is $58.19 and its two-hundred day moving average price is $59.07.

Invesco Dynamic Biotechnology & Genome ETF Profile

(Get Rating)

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Read More

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Want More Great Investing Ideas?

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.